Sobi to present new data at the 2023 EHA congress
Sobi® will present data at the EHA (European Haematology Association) hybrid congress taking place in Frankfurt, Germany 8-11 June, 2023, highlighting the company’s commitment in rare haematological diseases. During the congress, Sobi will present important new data on haemophilia, immune thrombocytopenia, relapsed or refractory diffuse large b-cell lymphoma (DLBCL), and paroxysmal nocturnal haemoglobinuria. “We look forward to discussing new data related to several of Sobi’s therapeutic areas with haematologists at this year’s EHA congress. This marks Sobi’s entry into onco-